A loading dose of study drug (clopidogrel 300 mg or placebo) was to be given as soon as treatment was allocated (Day 1). Patients were then treated with study drug (clopidogrel 75 mg daily or matching placebo) for the duration of follow-up. ASA therapy was to be started simultaneously with the study drug or patients continued with pre-admission ASA therapy, as applicable.